The first participant has been dosed in Foresee's Phase 2 trial testing the experimental oral therapy mirivadelgat in people ...

Between PH and a transplant, columnist Anna Jeter has often struggled with loneliness and isolation as someone with chronic ...

Patients and clinicians endorsed Opsynvi as a single-tablet combination therapy for PAH in interviews conducted during a ...

A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

Using a machine-learned algorithm, Corvista's system can accurately diagnose pulmonary hypertension in a noninvasive way, a ...

Synhale has acquired telaglenastat, and is planning a Phase 2 clinical trial testing the therapy in patients with pulmonary ...

There are night owls and morning larks, writes columnist Colleen Steele, referring to people's sleep habits. So which bird are you?